Daicel Corporation
Research Daicel Corporation (4202.T) on Bullrun: market cap JPY 376.24B, P/E 38.4, dividend yield 4.5%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4202.T
- ExchangeTSE
- CountryJapan
- SectorBasic Materials
- IndustrySpecialty Chemicals
- CurrencyJPY
- Market capJPY 376.24B
- P/E38.4
- Dividend yield4.5%
- Financial periodFY2026
- RevenueJPY 579.63B
- Revenue growth-1.2%
- Net incomeJPY 10.18B
- Free cash flow-JPY 178.00M
- Gross margin25.2%
Valuation Snapshot
latest market cap is JPY 376.24B; P/E is 38.4; dividend yield is 4.5%.
Peer valuation comparison
Latest P/E is 38.36x versus a Basic Materials sector median of 15.25x (151.6% above).
Latest dividend yield is 4.49% versus a Basic Materials sector median of 2.61% (72.4% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | JPY 579.63B | JPY 10.18B | -JPY 178.00M | 25.2% | 38.75 | JPY 68.81B | JPY 304.25B | JPY 355.60B |
| FY2025 | JPY 586.53B | JPY 49.48B | JPY 21.06B | 28.1% | 181.44 | JPY 65.14B | JPY 280.92B | JPY 359.98B |
| FY2024 | JPY 558.06B | JPY 55.83B | JPY 7.52B | 28.5% | 138.87 | JPY 73.18B | JPY 299.79B | JPY 359.44B |
| FY2023 | JPY 538.03B | JPY 40.68B | -JPY 25.08B | 27.1% | 138.87 | JPY 93.84B | JPY 317.83B | JPY 295.21B |
| FY2022 | JPY 467.94B | JPY 31.25B | -JPY 4.48B | 29.6% | 104.14 | JPY 88.13B | JPY 280.50B | JPY 272.02B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 376.24B | 38.4 | 4.8% | 70 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 70 JPY, yield 4.5%.
| Year | Dividends/share |
|---|---|
| FY2026 | 65 JPY |
| FY2025 | 60 JPY |
| FY2024 | 55 JPY |
| FY2023 | 45 JPY |
| FY2022 | 0.2 JPY |
About Daicel Corporation
Daicel Corporation engages in the materials, medical/healthcare, smart, safety, and engineering plastics businesses in Japan and internationally. The company offers medical/healthcare products, including BELLOCEA S7, a spherical cellulose acetate particle; FLAVOCELL S-Equol; Urolithin A; polyglycerols; konjac ceramide; excipients for foods; chiral columns and reagents; and Actranza lab, as well as separation and analytical services.
Related stock research
Other Basic Materials stocks
Frequently asked questions
What is Daicel Corporation's market cap?
Daicel Corporation's market capitalization is JPY 376.24B.
What is Daicel Corporation's P/E ratio?
Daicel Corporation's price-to-earnings (P/E) ratio is 38.4.
Does Daicel Corporation pay a dividend?
Daicel Corporation has a dividend yield of 4.5%.
What does Daicel Corporation do?
Daicel Corporation engages in the materials, medical/healthcare, smart, safety, and engineering plastics businesses in Japan and internationally. The company offers medical/healthcare products, including BELLOCEA S7, a spherical cellulose acetate particle; FLAVOCELL S-Equol; Urolithin A; polyglycerols; konjac ceramide; excipients for foods; chiral columns and reagents; and Actranza lab, as well as separation and analytical services.